CXCR4 and HIV-1 infection: Although the host immune surveillance may explain, at least in part, the absence of CXCR4- using variants during the asymptomatic phase of HIV-1 infection, it cannot justify the apparent scarcity of CXCR4-using variants in the very early phase of infection when neutralizing antibodies and cytotoxic T lymphocytes are still absent.